(Q56004533)
Statements
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619 (English)
0 references
1 March 1993
0 references
13
0 references
3
0 references
421-426
0 references